BOSSI, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 700
NA - Nord America 215
EU - Europa 27
SA - Sud America 5
AF - Africa 2
Totale 949
Nazione #
SG - Singapore 506
US - Stati Uniti d'America 215
CN - Cina 184
IT - Italia 15
BR - Brasile 5
HK - Hong Kong 4
IE - Irlanda 4
ES - Italia 2
FI - Finlandia 2
IN - India 2
VN - Vietnam 2
DE - Germania 1
DZ - Algeria 1
GB - Regno Unito 1
MY - Malesia 1
NG - Nigeria 1
NL - Olanda 1
SE - Svezia 1
TH - Thailandia 1
Totale 949
Città #
Singapore 322
Shanghai 184
Boardman 25
Chandler 12
Santa Clara 11
Genoa 6
Milan 6
São Paulo 5
Wilmington 5
Dublin 4
Hong Kong 4
San Mateo 4
Ann Arbor 2
Catania 2
Hanoi 2
Helsinki 2
Lawrence 2
New Delhi 2
Pamplona 2
Princeton 2
Amsterdam 1
Benin City 1
Constantine 1
Falkenstein 1
Leawood 1
London 1
Mercogliano 1
Subang Jaya 1
Woodbridge 1
Totale 613
Nome #
Role of Radiotherapy in the management of metastases from salivary gland carcinoma. 38
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 21
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 9
The Case Volume Issue in Head and Neck Oncology 7
Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New Challenges 7
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN) 7
Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis 7
Precision medicine in head and neck cancer: from immunotherapy to microbiota, circulating DNA and robotic surgery 7
Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach, part II: radiation technique and fractionations 7
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 7
A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes 7
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 6
Timing of chemoradiotherapy and patient selection for locally advanced nasopharyngeal carcinoma 6
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] 6
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic 6
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer 6
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study 6
ESMO Guidelines: Cancer patient management during the COVID-19 pandemic 6
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 5
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 5
Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review 5
Radiotherapy for unresectable sinonasal cancers: Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy 5
Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients 5
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer 5
Malignant salivary gland tumours in families with breast cancer susceptibility 5
Advances in the changing patterns of aetiology of head and neck cancers 5
Why Oncologists Should Feel Directly Involved in Persuading Patients with Head and Neck Cancer to Quit Smoking 5
Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients 5
Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer? [15] 5
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy 5
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy 5
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy 5
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 5
Is PSA useful in the diagnosis and monitoring of parotid adenocarcinomas? 5
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma 5
Regionally advanced nasopharyngeal carcinoma: Long-term outcome after sequential chemotherapy and radiotherapy 5
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 5
Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling 5
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 5
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma 5
Acquired resistance to Hedgehog inhibitor through smoothened mutation in basal cell carcinoma 5
A multidisciplinary approach to squamous cell carcinomas of the head and neck: What is new? 5
Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters 5
Treatment of cutaneous squamous cell carcinoma with immune checkpoint inhibitors in special populations 5
Head and neck tumors other than squamous cell carcinoma 5
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy 5
Description of adverse events in publications of clinical trials: Much room for improvement [La descrizione delle tossicità negli studi clinici: Molti aspetti da migliorare] 5
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil (TPF) induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced nasopharyngeal cancer (LANPC) 5
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents 5
A nationwide survey among emergency physicians and oncologists to improve the management of immune checkpoint inhibitors toxicity 5
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 5
Optimizing the treatment of nasopharyngeal cancer: Anupdate of the milan experience including imrt and chemotherapy intensification 5
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines 5
Quality Assessment in Supportive Care in Head and Neck Cancer 5
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancer 5
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia 5
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies? 4
Could the extreme conformality achieved with proton therapy in paranasal sinuses cancers accidentally results in a high rate of leptomeningeal progression? 4
HEALTHCARE ASSOCIATED INFECTIONS IN HEAD AND NECK CARCINOMA PATIENTS TREATED WITH CHEMOTHERAPY AND/OR RADIOTHERAPY 4
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients 4
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab 4
M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy – A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 4
Prognostic role of baseline 18 F‐FDG pet/CT in squamous cell carcinoma of the paranasal sinuses 4
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma 4
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 4
Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: Systematic review and meta-analysis 4
Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis 4
Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy 4
Immunotherapy for Nasopharyngeal Carcinoma 4
FURTHER IMPROVEMENT IN OUTCOMES OF NASOPHARYNGEAL CARCINOMA WITH OPTIMIZED RADIOTHERAPY AND INDUCTION PLUS CONCOMITANT CHEMOTHERAPY: AN UPDATE OF THE MILAN EXPERIENCE 4
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers 4
Cisplatin dose intensity correlates with outcome in patients with locally advanced head and neck squamous cell carcinoma receiving concurrent cisplatin based chemoradiation: a multi-institutional experience 4
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 4
Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature 4
Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents 4
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 4
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC) 4
Palifermin in Prevention of Head and Neck Cancer Radiation-Induced Mucositis: Not Yet a Definitive Word on Safety and Efficacy Profile 4
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 4
Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis 4
Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases 4
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 4
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy 4
Herceptin® plus chemotherapy in relapsed and/or metastatic salivary gland cancer [1] 4
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 4
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements 4
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma 4
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial 4
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders 4
T-cell therapy for the control of EBV-related nasopharyngeal carcinoma 4
Cost-effectiveness of Molecular Profile Patient Selection for First-line Treatment of Recurrent/Metastatic Head and Neck Cancer 4
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) 4
Stability of circulating miRNA in saliva: The influence of sample associated pre-analytical variables 4
In Reply to Fakhry et al 4
Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines 4
Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract 4
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 4
Lenvatinib-induced renal failure: two first-time case reports and review of literature 4
Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods 4
Primary resistances to EGFR inhibitors (EGFRi) in HPV-positive and -negative oropharyngeal squamous cell carcinoma (OSCC) 4
Totale 532
Categoria #
all - tutte 17.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 3 1 1 2 1 0 2
2021/20224 0 0 0 2 0 0 0 1 0 0 1 0
2022/202334 4 0 2 4 5 3 0 1 11 2 1 1
2023/20241.238 2 2 6 0 0 0 1 434 40 49 250 454
2024/202549 49 0 0 0 0 0 0 0 0 0 0 0
Totale 1.335